Status: Recruiting
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
This study intends to evaluate the safety and exploratory efficacy of transplantation therapy using neural precursor cells (PSA-NCAM(+) NPC) derived from the human embryonic stem cell line for the treatment of paralysis and other related symptoms from sub-acute spinal cord injury.
Participants needed: 5
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: S.Biomedics Co., Ltd.Updated: May 18, 2025Locations: 2
Eligibility criteria
Upon written consent of the patient or the legally acceptable representative of... [+5]
Patients with spinal cord injury caused by penetrating trauma such as gunshot or... [+28]